BillionToOne, Inc. (BLLN): Total Assets
$632.65M
As of 2025-12-31
$729.70M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $632.65M | +109.4% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $302.06M | n/a | 2026-03-11, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare BLLN, FLGT, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗